Cargando…

Prevalence of Acute Blood Transfusion Reactions in Mazandaran Heart Center, Sari, Iran, 2010-2012

INTRODUCTION: Although blood transfusion is life saving for patients, it is responsible for a series of complications and exposes the patients to a variety of risks. Therefore knowing different adverse effects of blood transfusion represents a great issue in managing recipient patients. AIM: The aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Azizi, Soheil, Tabary, Shervin Ziabakhsh, Soleimani, Arya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AVICENA, d.o.o., Sarajevo 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272498/
https://www.ncbi.nlm.nih.gov/pubmed/24937941
http://dx.doi.org/10.5455/medarh.2014.68.137-139
Descripción
Sumario:INTRODUCTION: Although blood transfusion is life saving for patients, it is responsible for a series of complications and exposes the patients to a variety of risks. Therefore knowing different adverse effects of blood transfusion represents a great issue in managing recipient patients. AIM: The aim of the present work was to study the prevalence of blood transfusion complications among patients in the Mazandaran Heart Center, Sari, Iran, during a period of 2 years. MATERIAL AND METHODS: A retrospective review of all reported and evaluated acute transfusion reactions during a 2 years period in Mazandaran Heart Center was performed. Associated clinical signs and symptoms were evaluated. RESULTS: In 9193 transfused blood products, there was 34 (0.4%) acute transfusion reactions. The commonest were discomfort and restlessness(0.16%), dyspnea(0.16%), rigors (0.13%), fever (0.08%), chest pain(0.06%), rash or urticaria (0.04%), nausea and vomiting(0.03%), palpitation(0.03%), hypertension(0.03%)flashing(0.02%), hypotension(0.02%). CONCLUSION: Acute transfusion reaction is seen in %0.4 of transfused patients therefore, we recommend a well-structured program for monitoring adverse reactions associated with blood transfusion and blood product administration (Hemovigilance program).